Sign in
4

Changes in Ownership

Entera Bio Ltd. Filed Acc 0001178913-22-003370

Options or other derivatives

  • Chief Financial Officer acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Yaacov-Garbeli Dana Chief Financial Officer 2022-09-07 Grant or award · Stock Option (right to buy) +35,000 35,000 D
Loading xslF345X03/ownership.xml…